Anlon Healthcare Limited (NSE:AHCL)

India · Delayed Price · Currency is INR

141.91

+0.68 (0.48%)

At close: Apr 17, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Manufacturing and Sale of Active Pharmaceutical Ingredients (APIs)	1.20B	666.16M	1.13B	573.89M	159.80M
Manufacturing and Sale of Active Pharmaceutical Ingredients (APIs) Growth	80.64%	-41.09%	97.04%	259.14%	-
Total	1.20B	666.16M	1.13B	573.89M	159.80M
Total Growth	80.64%	-41.09%	97.04%	259.14%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
India	1.16B	599.73M	1.01B	476.81M	148.63M
India Growth	94.07%	-40.53%	111.51%	220.81%	-
Export	38.97M	66.11M	120.26M	94.61M	10.98M
Export Growth	-41.06%	-45.03%	27.11%	761.42%	-
Unallocated	-	-	-	-	185.34K
Total	1.20B	665.84M	1.13B	571.43M	159.80M
Total Growth	80.65%	-41.01%	97.54%	257.60%	-

Source: S&P Global Market Intelligence.